Model
Edge
Revance Therapeutics Inc.
0001803375
Filing Type
144
Filing Date
9/5/2023
Updated
9/6/23, 10:21 AM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities